SANUWAVE Health, Inc. SNWV Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by SANUWAVE Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SANUWAVE Health, Inc.'s business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SANUWAVE Health, Inc.'s business segments — R&D?
- SANUWAVE Health, Inc. (SNWV) reported business segments — R&D of $660K in Q1 2026.
- How has SANUWAVE Health, Inc.'s business segments — R&D changed year-over-year?
- SANUWAVE Health, Inc.'s business segments — R&D increased by 217.3% year-over-year, from $208K to $660K.
- What is the long-term trend for SANUWAVE Health, Inc.'s business segments — R&D?
- Over 2 years (2023 to 2025), SANUWAVE Health, Inc.'s business segments — R&D has grown at a 52.9% compound annual growth rate (CAGR), from $579K to $1.35M.
- What does business segments — R&D mean?
- Reflects the investment in innovation, product design, and technical improvements within the business segment. High spending in this area indicates a focus on long-term product competitiveness and future growth potential.